Monoclonal Antibody Treatment After Surgery Reduces the Risk of Breast Cancer Returning

Treating women diagnosed with one type of early-stage breast cancer with the monoclonal antibody trastuzumab after surgery reduces the risk of the cancer returning, reports...
The post Monoclonal Antibody Treatment After Surgery Reduces the Risk of Breast Cancer Returning appeared first on SciTechDaily.